Female Sexual Dysfunction Global Clinical Trials Review H2 2017

Region:Global

Author(s):

Product Code:GDHC4747CTIDB

Download Sample Report download
Buy the Full ReportStarting from $2500
Published on

December 2017

Total pages

158

Table of Content

Download Sample Report download
Buy the Full ReportStarting from $2500

About the Report

About the Report

Female Sexual Dysfunction Global Clinical Trials Review, H2, 2017

Summary

GlobalData'sclinical trial report, �Female Sexual Dysfunction Global Clinical Trials Review, H2, 2017" provides an overview of Female Sexual Dysfunction clinical trials scenario. This report provides top line data relating to the clinical trials on Female Sexual Dysfunction. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData'sproprietary database-Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

The report provides a snapshot of the global clinical trials landscape

Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status

The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company

The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment

The Report provides enrollment trends for the past five years

Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to Buy

Assists in formulating key business strategies with regards to investment

Helps in identifying prominent locations for conducting clinical trials which saves time and cost

Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities

Supports understanding of trials count and enrollment trends by country in global therapeutics market

Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials

Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Products


Companies

Sprout Pharmaceuticals Inc

Emotional Brain BV

Pfizer Inc

Allergan Plc

C. H. Boehringer Sohn AG & Co KG

ANI Pharmaceuticals Inc

Vivus Inc

Palatin Technologies Inc

Acerus Pharmaceuticals Corp

Apricus Biosciences Inc

Table of Contents

Table of Contents

Table of Contents

List of Tables

List of Figures

Report Guidance

GlobalData Clinical Trials Report Coverage

Clinical Trials by Region

Clinical Trials and Average Enrollment by Country

Top Five Countries Contributing to Clinical Trials in Asia-Pacific

Top Five Countries Contributing to Clinical Trials in Europe

Top Countries Contributing to Clinical Trials in North America

Top Five Countries Contributing to Clinical Trials in Middle East and Africa

Top Countries Contributing to Clinical Trials in Central and South America

Clinical Trials by G7 Countries: Proportion of Female Sexual Dysfunction to Women'sHealth Clinical Trials

Clinical Trials by Phase in G7 Countries

Clinical Trials in G7 Countries by Trial Status

Clinical Trials by E7 Countries: Proportion of Female Sexual Dysfunction to Women'sHealth Clinical Trials

Clinical Trials by Phase in E7 Countries

Clinical Trials in E7 Countries by Trial Status

Clinical Trials by Phase

In Progress Trials by Phase

Clinical Trials by Trial Status

Clinical Trials by End Point Status

Subjects Recruited Over a Period of Time

Clinical Trials by Sponsor Type

Prominent Sponsors

Top Companies Participating in Female Sexual Dysfunction Therapeutics Clinical Trials

Prominent Drugs

Clinical Trial Profile Snapshots

Appendix

Abbreviations

Definitions

Research Methodology

Secondary Research

About GlobalData

Contact Us

Source


List of Figure

List of Figures

Female Sexual Dysfunction Therapeutics, Global, Clinical Trials by Region (%), 2017*

Female Sexual Dysfunction Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017*

Female Sexual Dysfunction Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017*

Female Sexual Dysfunction Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2017*

Female Sexual Dysfunction Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2017*

Female Sexual Dysfunction Therapeutics Clinical Trials, North America, Top Countries (%), 2017*

Female Sexual Dysfunction Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2017*

Female Sexual Dysfunction Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2017*

Proportion of Female Sexual Dysfunction to Women'sHealth Clinical Trials, G7 Countries (%), 2017*

Female Sexual Dysfunction Therapeutics, G7 Countries, Clinical Trials by Phase, 2017*

Female Sexual Dysfunction Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017*

Proportion of Female Sexual Dysfunction to Women'sHealth Clinical Trials, E7 Countries (%), 2017*

Female Sexual Dysfunction Therapeutics, E7 Countries, Clinical Trials by Phase, 2017*

Female Sexual Dysfunction Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017*

Female Sexual Dysfunction Therapeutics, Global, Clinical Trials by Phase (%), 2017*

Female Sexual Dysfunction Therapeutics, Global, Clinical Trials In Progress by Phase, 2017*

Female Sexual Dysfunction Therapeutics, Global, Clinical Trials by Trial Status, 2017*

Female Sexual Dysfunction Therapeutics Clinical Trials, Global, by End Point Status, 2017*

Female Sexual Dysfunction Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016

Female Sexual Dysfunction Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2017*

Female Sexual Dysfunction Therapeutics Clinical Trials, Global, Key Sponsors, 2017*

Female Sexual Dysfunction Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017*

Female Sexual Dysfunction Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017*

GlobalData Methodology


List of Table

List of Tables

Female Sexual Dysfunction Therapeutics, Global, Clinical Trials by Region, 2017*

Female Sexual Dysfunction Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017*

Female Sexual Dysfunction Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017*

Female Sexual Dysfunction Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2017*

Female Sexual Dysfunction Therapeutics Clinical Trials, Europe, Top Five Countries, 2017*

Female Sexual Dysfunction Therapeutics Clinical Trials, North America, Top Countries, 2017*

Female Sexual Dysfunction Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2017*

Female Sexual Dysfunction Therapeutics Clinical Trials, Central and South America, Top Countries, 2017*

Proportion of Female Sexual Dysfunction to Women'sHealth Clinical Trials, G7 Countries (%), 2017*

Female Sexual Dysfunction Therapeutics, G7 Countries, Clinical Trials by Phase, 2017*

Female Sexual Dysfunction Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017*

Proportion of Female Sexual Dysfunction to Women'sHealth Clinical Trials, E7 Countries (%), 2017*

Female Sexual Dysfunction Therapeutics, E7 Countries, Clinical Trials by Phase, 2017*

Female Sexual Dysfunction Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017*

Female Sexual Dysfunction Therapeutics, Global, Clinical Trials by Phase, 2017*

Female Sexual Dysfunction Therapeutics, Global, Clinical Trials In Progress by Phase 2017*

Female Sexual Dysfunction Therapeutics, Global, Clinical Trials by Trial Status, 2017*

Female Sexual Dysfunction Therapeutics Clinical Trials, Global, by End Point Status, 2017*

Female Sexual Dysfunction Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016

Female Sexual Dysfunction Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2017*

Female Sexual Dysfunction Therapeutics Clinical Trials, Global, Key Sponsors, 2017*

Female Sexual Dysfunction Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017*

Female Sexual Dysfunction Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017*

You can also purchase parts of this report.
Do you want to check out a section wise price list?
Get Price Break-up

Why Buy From US?

RRR
Refine Robust Result (RRR) Framework

What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story

reach
Our Reach Is Unmatched

We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.

Research
Shifting the Research Paradigm

While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.

Insite
More Insights-Better Decisions

With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.

Trust
Transparency and Trust

Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.

support
Round the Clock Support

If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.

Why Client Choose Us?

400000+ Reports in repository
150+ Consulting project a year
100+ Analysts
8000+ Client Queries in 2022